TIME LAPSE
The computed 12-month bankruptcy probability of TIME LAPSE is 2.2% (moderate). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 10 yrs |
| Publications | 2 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2021 | micro | 28-07-2022 | 2022-20249861 |
| 31-12-2020 | micro | 27-08-2021 | 2021-55500081 |
| 31-12-2019 | micro | 27-08-2020 | 2020-45600075 |
| 31-12-2018 | micro | 25-07-2019 | 2019-38700586 |
| 31-12-2017 | micro | 19-08-2018 | 2018-47300431 |
| 31-12-2016 | micro | 10-08-2017 | 2017-42500448 |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 09-02-2016 |
| Status | Active |
| Postal code | 1082 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21342B0108/00S005 | Brussels | 127 m² | 1 · 73 m² | 14.9 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
03-03-2023 Change in the board of directors
Technical details
{
"events": [],
"notary": {
"name": "Charles HUYLEBROUCK",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-03-03",
"filing_date": "2023-03-01",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2023-02-21",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0647.951.783",
"name_full": "JAL-BIOHOME",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Charles HUYLEBROUCK",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"une exp\u00E9dition",
"les statuts coordonn\u00E9s"
],
"corrected_publication_numac": null
}11-03-2022 All shares are now held by a single shareholder
Technical details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Bitefelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2022-03-11",
"filing_date": "2022-03-04",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2021-12-31",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2021-12-31"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0647.951.783",
"name_full": "JAL-BIO\u041D\u041E\u041C\u0415",
"legal_form": "SPRL",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "RIECHELMANN Hendrik Laurent",
"role": null,
"n_shares": 0,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "SYLLA AROUNA Imane",
"role": null,
"n_shares": 70,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "SYLLA Zainab",
"role": null,
"n_shares": 30,
"share_class": null
}
],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | TIME LAPSE |